newsfilter
← Latest News
Business Wire·

Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue

MHRA guidance aligns on key measurements for a registration trial, including primary endpoint and trial design elements IND for phase 2b/3 trial submitted to the FDA Axcella to host a conference call Tuesday, January